1.Preliminary proteomic study on protective mechanism of carvedilol pre-treatment for ischemia-reperfusion heart injury in rats
Journal of Chongqing Medical University 2007;0(09):-
Objective:To investigate the changes of the protein expression in heart tissue of rats after ischemia-reperfusion(I/R) injury and pre-treatment of carvedilol, and to elucidate the new protective mechanism of carvedilol pre-treatment to I/R heart injury. Methods:18 rats were randomly divided into sham-operation group, I/R injury group and carvedilol pre-treated group. The model of myocardial I/R injury was established by 30min ligation of the left anterior descending branch of the coronary artery and 2h reperfusion. Serum malondiadehyde (MDA) was determined, and the cytosolic fraction of myocardial tissue homogenate was separated applying two-dimensional gel electrophoresis technique. Differentially expressed protein spots were figured out with PDQuest software, while preliminary protein-identification was carried out by means of the two-dimensional gel electrophoresis database on the web. Results:Compared with the sham-operation group, after I/R injury, serum MDA was increased(P
2.Effect of resin infiltration treatment on the colour of white spot lesions.
West China Journal of Stomatology 2014;32(3):306-309
OBJECTIVEThis study aimed to evaluate the effect of resin infiltration and fluoride solution on masking different demineralized white spot lesions by assessing color change.
METHODSArtificial white spot lesions were produced on 60 human molars. Each sample had at least two enamel surfaces opened (named A and B). The samples were randomly divided into groups 1, 2, and 3 according to their time of demineralization (24, 48, and 72 h). After demineralization, the A spot of each sample was treated by resin infiltration. The B spot was treated with 0.1% fluoride solution daily for 30 days. After the remineralization of the B spot, resin infiltration was used again on the B spot of each sample. Color assessment was performed by a spectrophotometer in five distinct stages: baseline, after the production of artificial caries, after resin infiltration of A spots, after 30 days of fluoride solution treatment of B spots, and after resin infiltration of remineralized B spots.
RESULTSBefore demineralization, the L* values of spots A and B in all groups were not significantly different (P > 0.05), whereas the L* values of spots A and B were significantly increased after demineralization. The L* values of A spots recovered significantly after treatment by resin infiltration (P<0.05), but only groups 1 and 2 reached the baseline. The L* values of B spots had no significant differences (P > 0.05) after fluoride treatment compared with that after demineralization. After resin infiltration on B spots, the L* values recovered but could not reach the baseline nor the level of A spots treated by resin infiltration only.
CONCLUSIONResin infiltration is a more effective treatment for masking white spot lesions than traditional fluoride treatment. The effect of masking white spot lesions has certain relationships with the degree of demineralization and activity of the lesion.
Color ; Dental Caries ; Dental Enamel ; Fluorides ; Humans ; Molar ; Phosphates ; Sodium Fluoride
3.The significance of immunohistochemical localization of MC5 in the diagnosis and prognosis of colorectal adenocarcinoma
Po ZHAO ; Fengxun GAO ;
Journal of Third Military Medical University 1983;0(03):-
The pattern of immunohistochemical localization of monoclonal antibody MC5 was observed in 215 cases of colarectal adenocarcinoma.It was found that the polarized pattern was predominant in the well-differentiated adenocarcinomas while the deffuse pattern in poorly-differentiated ade-nocarcinomas.Followup study of 133 cases revealed that 5-year sunvival rate was 74.4% in cases with polarized pattern and 36.2% in those with diffuse pattern,a very significant difference between the 2 (P
4.Research progress of CAR T-cell in tumor therapy
Chinese Journal of Clinical Oncology 2015;(3):190-194
Adoptive cell transfusion based on chimeric antigen receptor (CAR) is a new approach for treating malignant diseases and even advanced malignancies. More patients with advanced malignancies are expected to benefit from CAR T-cells once the suitable target molecules are selected, the safe method of gene transduction is applied, and the side effects of CAR T-cells are prevented.
5.The importance of appling laboratory tests in diagnosing hemophagocytic lymphohistocytosis
Chinese Journal of Laboratory Medicine 2015;38(11):727-729
It is a challenge in diagnosis of hemophagocytic lymphohistocytosis (HLH).Rapid diagnosis is the key to make decisions in clinical management of HLH.The timely and reliable diagnosis of HLH can be assisted by laboratory tests including nature killer (NK) cell activity, sCD25, hemophagocytosis, ferritin, surface CD107a, and genetic testing.Here is introduced lab assays and evaluate the clinical applications in HLH.The aim is to raise awareness of the values of laboratory evaluations in diagnosing HLH.
6.Role of Nrf2/Keap1/ARE signaling pathway in respiratory diseases
Chinese Pharmacological Bulletin 2015;(11):1488-1492
Nrf2/Keap1/ARE is an important signaling pathway in maintaining the balance between peroxide and antioxidants. Once oxidative stress happened, Nrf2/Keap1/ARE would be ac-tivated to regulate the expression of downstream antioxidant pro-teins that could reduce the injury from oxidative stress and the level of oxidative stress. Recent researches show that Nrf2/Keap1/ARE signaling pathway is closely related to refractory re-spiratory diseases such as pulmonary fibrosis (PF), lung canc-er, chronic obstructive pulmonary disease (COPD), suggesting that Nrf2/Keap1/ARE signaling pathway may be a potential ther-apeutic target. This review focuses on the role of Nrf2/Keap1/ARE signaling pathway in refractory respiratory diseases in order to further understand the related mechanism and provide evidence for the diagnosis and treatment of refractory respiratory diseases.
7.Incidence and related factors research of vascular cognitive impairment after acute subcortical infarction
Chinese Journal of Postgraduates of Medicine 2012;35(4):5-7
Objective To discuss incidence and related risk factors of vascular cognitive impairment (VCI) after acute subcortical infarction (SI).Methods One hundred and eighty-two patients with acute SI were divided into two groups:VCI group (81 cases) and no-VCI group ( 101 cases) according to VCI diagnostic standard.Sex proportion,age,culture degree between two groups were compared,and correlation was analyzed between the quantity of risk factors and the incidence of VCI.Results The incidence of VCI after acute SI was 44.5%(81/182).According to age stratification,the incidence of VCI in the patients of 56-65 years was 35.4% (23/65),in the patients of 66-75 years was 45.3% (48/106),and in the patients of 76-85 years was 90.9% (10/11 ).The age in VCI group was significantly higher than that in no-VCI group [(69.93 ±6.91) years vs. (67.62 ±5.56) years,P =0.014],and culture degree was significantly lower than that in no-VCI group (P =0.028).The sex proportion between two groups had no significant difference (P =0.876).The more accompanying risk factors,the higher incidence of VCI.Conclusions Along with the increase of age,the incidence of VCI after acute SI is higher.The more accompanying risk factors,the higher incidence of VCI.
8.A comparative study of the effects of four kinds of drugs on periodontitis-related cytokines of rats
Journal of Practical Stomatology 2010;26(1):47-50
Objective: To explore rational drug usage for periodontitis treatment through a comparative study of the efficacy of four kinds of drugs on the experimental periodontitis. Methods: 126 Wistar rats,10 randomly selected as normal control group, the other 116 were modeled by using local wire ligation and systemic prednisolone acetate injection. Successful animal models were randomly divided into model control group and berberine hydrochloride, minocycline hydrochloride, ginsenoside Rg-1 and transforming growth factor-β1 treatment groups, which were treated with each kind of medicine separately and were killed at the end of 1, 2, 4 weekend. Detected IL-1β, TNF-α, IL-6, BGP levels by immunohistochemical SABC assay. Results: IL-1β, TNF-α, IL-6 of the treatment groups were lower and BGP was higher than model control group(P<0.05).Among them, the role of berberine hydrochloride to reduce IL-1β and TNF-α was the best. The role of minocycline hydrochloride to reduce IL-6 was the fastest. The role of transforming growth factor-β1 to increase BGP was the fastest. The role of ginsenoside Rg-1 to increase BGP was more lasting and better follow-up. Berberine and ginsenoside Rg-1 reduced IL-1β, TNF-α, IL-6 and increased BGP at the same time. Conclusion: The treatment of minocycline hydrochloride and transforming growth factor-β1 are quick. Berberine and ginsenoside Rg-1, particularly berberine have the advantage of multi-targets' role.
9.TNF-α expression induced by NF-κB in pulmonary intravascular macrophages of rats with hepatopulmo-nary syndrome and the effect of pyrrolidine dithiocarbamate on the expression
Clinical Medicine of China 2008;24(10):993-996
Objective To study the expression of both nuclear factor-κB(NF-κB)and tumor necrosis fac-tor-α(TNF-α)in pulmonary intravascular macrophages(PIM)of rats with hepatopulmonary syndrome (HPS)and the effect of pyrrolidine dithiocarbamate(PDTC)on their expression.Methods The Sprague-Dawley(SD)rats were randomly divided into four groups:control,control+PDTC1CCl4,CCl4+PDTC groups.Arterial blood was collected for measurement of blood gas.Venous blood was sampled for hepatic function and endotoxin level.The mesenteric lymph nodes were dissected for bacteriology studies.Proteins of NF-κB and TNF-a of lung tissue were examined by immunohistochemistry.The activity of NF-κB in lung tissues was measured using electrophoretic mobility shift assay (EMSA).By real-time polymerase chain reaction (PCB)using SYBR Green I,the mRNA expression of TNF-α in lung tissues were detected.Results CCl4 group developed HPS with decreased PaO2 and PaCO2,increased alveolar-arterial oxygen difference(A-aDO2),abnormal hepatic function and increased endotoxin level.Culture-positive mes-enteric lymph nodes were found in 62.5%(5/8)of CCl4,group and 66.7%(6/9)of CCl4+PDTC group(P>0.05 J.All lungs from CCl4 and CCl4+PDTC group showed no accumulation of larse mononuclear macrophagelike cells within the lumen of numerous small muscular and nonnulscular pulmonary vessels.The percentages of vessels with more than 1O adherent macrophages was 60.8%(292/480)in CCl4 group but only 19.6%(106/540)in CCl4+PDTC group(P<0.01).The protein expression of NF-κB and TNF-α Was localized to PIM in CCl4 group.The NF-κB activity and mRNA expression of TNF-α in CCl4 group was significantly higher than that in control,con-trol+PDTC group and CCl4+PDTC group(P<0.05).Conclusion The TNF-α expression in PIM induced by NF-κB play an important role in HPS.The inhibitor of NF-κB PDTC can repress PIM activation and decrease the ex-pression of TNF-α.As result.HPS severity is reduced.
10.Metabolic syndrome and hepatocellular carcinoma:an advance in epidemiology study
Academic Journal of Second Military Medical University 1981;0(04):-
Hepatocellular carcinoma(HCC) is the fifth most common cancer and the third cause of cancer-related death worldwide;meanwhile,it is also one of the fastest growing malignancies.The causes of HCC are multiple;HBV is the most important cause in China,with about 25%-30% of HBV infection patients finally develop hepatic cirrhosis and liver cancer.At present,large scale epidemiological studies revealed that the metabolic syndrome(MS) was closely related to liver cancer,and it even served as an independent risk factor for the occurrence and progression of liver cancer.Non-alcoholic fatty liver disease is a metabolic syndrome clinically manifested in the liver;recently it has been indicated to be closely related with HCC development and progression.This paper reviews the recent researches on metabolic syndrome and liver cancer,so as to provide literature for preventive and therapeutic studies on non-virus-related liver cancer.